Cancer Vaccines Ltd Company Profile

13:14 EDT 25th September 2018 | BioPortfolio

Cancer Vaccines Ltd is a biopharmaceutical company focused on the development and commercialisation of safe and effective therapeutic vaccines for the treatment of cancer. The company was founded in 1999 and won a DTI SMART Award.The attraction of a vaccination based approach to treating cancer is widely acknowledged, and many researchers and clinicians have worked in this area. Historically the approach was based on the injection of cellular preparations displaying antigens associated with but not necessarily unique to the cancer being treated.The founders of Cancer Vaccines Ltd (CVL) were the first to identify the power of combining a cell-based vaccine with the targeting of the antigens generated by the cancer-causing genes of the target cancers. This approach was granted patent protection in the USA in 2001 and patents are currently pending in Europe and Japan.Clinical trials with a prototype of the Company's first product demonstrate safety and the generation of appropriate immune responses in the trial patients.The CVL approach is cheaper to produce than many other cellular vaccines, standardised (i.e. is not specific to each individual patient) and suitable for treating large numbers of patients. It offers the opportunity to rapidly develop a family of products addressing multiple markets.


18 Common Lane
United Kingdom


Phone: 44 (0) 1926 864435
Fax: 44 (0) 1926 864559

News Articles [2280 Associated News Articles listed on BioPortfolio]

This Austrian Biotech is Developing Vaccines for Pancreatic and Breast Cancer

This week, we’re in Vienna, Austria, visiting OncoQR, a biotech specializing in therapeutic cancer vaccines for patients with pancreatic and breast cancer. Mission: OncoQR develops cancer vaccines t...

Moderna and Merck expand partnership to develop new cancer vaccines

Moderna and Merck & Co have expanded their partnership to develop and commercialise novel personalised messenger RNA (mRNA) cancer vaccines. This expansion of their 2016 collaboration will inclu...

Cancer Vaccines Market Report 2018 – Global Industry Analysis 2016-2024 –

DUBLIN–(BUSINESS WIRE)–The “Cancer Vaccines Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024” report has been added to̵...

Oxford Vacmedix Raises $12.5 Million for Therapeutic Vaccines from Asian Investors

Oxford Vacmedix, a UK-Changzhou biopharma, closed a $12.5 million Series A funding from South Korean and China investors to develop therapeutic cancer vaccines. OVM's two lead vaccines target cervical...

This Dutch Biotech Develops Cancer Vaccines and Cell Therapies

Today we’re in Maastricht, the Netherlands, visiting CiMaas. The biotech is harnessing two types of immune cells in its cancer vaccines and cell therapies. Mission: CiMaas started in 2015 as a spin-...

Merck and Moderna Expand Cancer Vaccine Partnership with Another $125 Million

Moderna Therapeutics and Merck expanded their 2016 collaboration deal to develop and commercialize personalized messenger RNA (mRNA) cancer vaccines. The new deal will include mRNA cancer vaccines tha...

LineaRx to Collaborate with Italian Companies Takis and Evvivax on Cancer Vaccines

LineaRx, a subsidiary of Applied DNA Sciences, has entered into a Joint Development Agreement with Takis SRL and Evvivax SLR. They will focus on developing anti-cancer vaccines.

Merck Beats Views On Sales Jumps For Cancer Drugs, Vaccines

NewsSoaring sales of cancer drugs, vaccines, and veterinary medicines drove Merck & Co.'s 5 percent jump in second-quarter revenue and the company lifted its outlook for the year.

PubMed Articles [6497 Associated PubMed Articles listed on BioPortfolio]

as a Vector for Cancer Immunotherapy: Current Understanding and Progress.

, a Gram-positive facultative anaerobic bacterium, is becoming a popular vector for cancer immunotherapy. Indeed, multiple vaccines have been developed utilizing modified as a tool for generating imm...

Cancer vaccines: translation from mice to human clinical trials.

Therapeutic cancer vaccines have been a long-sought approach to harness the exquisite specificity of the immune system to treat cancer, but until recently have not had much success as single agents in...

HER2-Based Immunotherapy for Breast Cancer.

Resistance to therapies and disease recurrences after surgery or treatment are common challenges in breast cancer management in clinic. Active immunotherapy using human epidermal growth factor recepto...

Immunizing Cancer Patients: Which Patients? Which Vaccines? When to Give?

Patients receiving treatment for cancer should be considered for age- and indication-appropriate vaccinations, and the responsibility for administration of these vaccines is shared between the oncolog...

Acceptability of HPV vaccines and associations with perceptions related to HPV and HPV vaccines among male baccalaureate students in Hong Kong.

The highly infectious human papillomavirus (HPV) causes both genital warts and cervical cancer in women. In 2009, the prevalence of genital warts in Hong Kong was 203.7 per 100,000 person-years. Cervi...

Clinical Trials [9282 Associated Clinical Trials listed on BioPortfolio]

A Study to Test the Safety of Three Experimental HIV Vaccines

The purpose of this study is to test three experimental HIV vaccines. This study will look at whether it is safe to give these vaccines together and how the immune system responds to the ...

S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer

RATIONALE: Vaccines made from a peptide may make the body build an immune response to kill cancer cells. PURPOSE: This phase I trial is studying two different vaccines to treat patients w...

Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers

Study to assess the ability of healthy subjects to build anitbodies to tetanus and pneumococcal vaccines after receiving a single intravenous dose of Abatacept, a drug which is being devel...

Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Randomized phase II trial to compare the effectiveness of two different vaccines in treating p...

A Study of the Immune Response to Vaccines and Ixekizumab (LY2439821) in Healthy Participants

The purpose of this study is to compare the body's immune response when vaccines are given alone versus when vaccines are given along with the study drug called ixekizumab. The vaccines p...

Companies [1738 Associated Companies listed on BioPortfolio]


It is a new and innovative cancer vaccine consisting of formalin-fixed or paraffin-embedded tissue fragments derived from patient's own cancer (tumor) and immunoadjuvants. It is one of the self-vaccin...

Cancer Vaccines Ltd

Cancer Vaccines Ltd is a biopharmaceutical company focused on the development and commercialisation of safe and effective therapeutic vaccines for the treatment of cancer. The company was founded in 1...

MabVax Therapeutics Inc.

MabVax was formed to commercialize the work of Dr. Phil Livingston and colleagues at Memorial Sloan-Kettering Cancer Center (MSKCC) who over the last 25 years have developed monovalent cancer vacc...


DCPrime develops off-the-shelf dendritic cell-based vaccines for a broad range of cancer types, based on its unique, proprietary technology platform, DCOne™. DCOne-based dend...

BioVaxys LLC

BioVaxys LLC, a privately-held, clinical stage biotechnology company that is developing highly-targeted, patient-specific, immunotherapeutic vaccines to treat various solid tumor ...

More Information about "Cancer Vaccines Ltd" on BioPortfolio

We have published hundreds of Cancer Vaccines Ltd news stories on BioPortfolio along with dozens of Cancer Vaccines Ltd Clinical Trials and PubMed Articles about Cancer Vaccines Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cancer Vaccines Ltd Companies in our database. You can also find out about relevant Cancer Vaccines Ltd Drugs and Medications on this site too.

Quick Search


Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Corporate Database Quicklinks

Searches Linking to this Company Record